Afero Cloud News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Afero partners with Therma Bright to make AcuVid™ COVID-19 Rapid Antigen Saliva Test smart-enabled Share Article Silicon Valley tech firm brings encrypted solution for tracking Canadian developer’s 15-minute Covid19 rapid antigen test for point of care, and then at-home testing LOS ALTOS, Calif. (PRWEB) April 28, 2021 Afero has entered into an agreement with Therma Bright TSXV(THRM.V), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, to bring grea...

(2) Silicon Valley tech firm brings encrypted solution for tracking Canadian developer's 15-minute Covid19 rapid antigen test for point of care, and then at-home testing Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - Afero has entered into a memorandum of understanding (MOU) agreement with Therma Bright Inc. (TSXV: THRM), the "Company" or "Therma Bright"), developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies. The mutually beneficial partnership looks to bring Afero's innovation, security and tracking technology to T...